Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald M Haase

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group studyDaphne A Haas-Kogan, Patrick S Swift, Michael Selch, et al.
CA: a Cancer Journal for Clinicians|December 10, 2002
National action plan for childhood cancer: report of the national summit meetings on childhood cancerRobert Arceci, Alice Ettinger, Edwin Forman, et al.
Journal of Pediatric Surgery|May 4, 2005
Quality assessment for Wilms' tumor: a report from the National Wilms' Tumor Study-5Peter F Ehrlich, Michael L Ritchey, Tomas E Hamilton, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2006
Radiation therapy for favorable histology Wilms tumor: prevention of flank recurrence did not improve survival on National Wilms Tumor Studies 3 and 4Norman E Breslow, J Bruce Beckwith, Gerald M Haase, et al.
Cancer|August 27, 2004
Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor StudiesNorman E Breslow, San-San Ou, J Bruce Beckwith, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study GroupJohn A Kalapurakal, Sierra M Li, Norman E Breslow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study GroupNita L Seibel, Sierra Li, Norman E Breslow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2005
Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study GroupPaul E Grundy, Norman E Breslow, Sierra Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor StudyJeffrey S Dome, Cecilia A Cotton, Elizabeth J Perlman, et al.
Annals of Surgery|February 10, 2010
Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5Robert C Shamberger, James R Anderson, Norman E Breslow, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group studyDaphne A Haas-Kogan, Patrick S Swift, Michael Selch, et al.
CA: a Cancer Journal for Clinicians|December 10, 2002
National action plan for childhood cancer: report of the national summit meetings on childhood cancerRobert Arceci, Alice Ettinger, Edwin Forman, et al.
Journal of Pediatric Surgery|May 4, 2005
Quality assessment for Wilms' tumor: a report from the National Wilms' Tumor Study-5Peter F Ehrlich, Michael L Ritchey, Tomas E Hamilton, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2006
Radiation therapy for favorable histology Wilms tumor: prevention of flank recurrence did not improve survival on National Wilms Tumor Studies 3 and 4Norman E Breslow, J Bruce Beckwith, Gerald M Haase, et al.
Cancer|August 27, 2004
Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor StudiesNorman E Breslow, San-San Ou, J Bruce Beckwith, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study GroupJohn A Kalapurakal, Sierra M Li, Norman E Breslow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study GroupNita L Seibel, Sierra Li, Norman E Breslow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2005
Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study GroupPaul E Grundy, Norman E Breslow, Sierra Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor StudyJeffrey S Dome, Cecilia A Cotton, Elizabeth J Perlman, et al.
Annals of Surgery|February 10, 2010
Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5Robert C Shamberger, James R Anderson, Norman E Breslow, et al.
Pageof 3